Exponent vs Onterris
EXPO and ONT side by side, both in management and public relations services. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How EXPO and ONT compare
Exponent is the larger company, worth 5.1 times as much as Onterris ($4.1B against $811M).
Exponent grew revenue faster over the last twelve months (15.4% versus −9.1% for Onterris).
Exponent keeps more of each dollar of sales as profit, with a net margin of 17.4% compared with −1.4% at Onterris.
Exponent pays a dividend yielding 1.4%; Onterris does not pay one.
Exponent scores higher on the StockData Score (20 against 11 for Onterris), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | EXPO | ONT |
|---|---|---|
| Size and price | ||
| Market cap | $4.1B | $811M |
| Share price | $86.22 | $23.08 |
| Change, 1 year | 21.5% | −4.6% |
| Change, 5 years | −31.1% | −69.7% |
| Beta (5Y) | 0.86 | 1.31 |
| Employees | 1,313 | 3,500 |
| StockData Score | ||
| Total score | 20 (better) | 11 |
| Valuation score | 2 | 4 (better) |
| Growth score | 3 | 3 |
| Performance score | 5 (better) | 1 |
| Health score | 6 (better) | 3 |
| Dividend score | 4 (better) | 0 |
| Valuation | ||
| P/E | 37.2× | – |
| P/S | 6.2× | 1.1× (better) |
| P/B | 13.3× | 1.8× (better) |
| EV/EBITDA | 26.4× | 18.6× (better) |
| P/FCF | 29.1× | 11.6× (better) |
| PEG | 20.23 | – |
| FCF yield | 3.4% | 8.6% (better) |
| Fair value | $70.07 | $38.65 |
| Margin of safety | −23.1% | 40.3% (better) |
| Growth | ||
| Revenue growth (TTM) | 15.4% (better) | −9.1% |
| Revenue growth, 5Y average | 7.8% | 20.4% (better) |
| Net income growth (TTM) | 9.4% | – |
| EPS growth (TTM) | 13.2% | – |
| EPS growth, 5Y average | 6.0% | – |
| Profitability | ||
| Gross margin | – | 41.5% |
| Operating margin | 21.3% (better) | 1.3% |
| Net margin | 17.4% (better) | −1.4% |
| FCF margin | 21.3% (better) | 9.3% |
| Return on equity | 32.3% (better) | −2.3% |
| Return on invested capital | 51.7% (better) | 1.1% |
| Financial health | ||
| Debt / equity | 0.00 | 0.72 (better) |
| Net debt / EBITDA | – | 5.04 |
| Current ratio | 1.93 (better) | 1.88 |
| Altman Z-score | 9.70 (better) | 1.50 |
| Piotroski F-score | 5 (better) | 4 |
| Dividends and buybacks | ||
| Dividend yield | 1.4% | – |
| Payout ratio | 53.2% | – |
| Years of dividend growth | 13 | – |
| Dividend growth, 5Y average | 9.6% | – |
| Buyback yield | 4.2% | – |
| Shareholder yield | 5.6% (better) | 0.00% |
| Ownership | ||
| Held by institutions | 97.8% | 108% |
| Held by insiders | 1.3% | 9.6% |
| Insider net buying, 12 months | −$2.7M (better) | −$5.2M |
| Short interest, % of float | 5.2% | 15.0% |
Go deeper
- EXPO stock overview
- EXPO income statement
- EXPO valuation and score
- ONT stock overview
- ONT income statement
- ONT valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.